,i  #aadth ,,congress  #b;d ,session    
,h4 ,r4 #eccg  ,,in ,,the ,,house ,,of  
,,representatives  ,may #bf1 #bjaf ,mr4 
,o',rourke 7for himself1 ,mr4 ,coffman1 
,miss ,rice of ,new ,york1 and ,ms4     
,titus7 introduced the following bill2  
which was referred to the ,committee on 
,veterans' ,affairs  ,a ,,bill  ,to     
ensure that an individual who is        
transitioning from receiving medical    
treatment furnished by the ,secretary of
 ,defense to medical treatment furnished
 by the ,secretary of ,veterans ,affairs
 receives the pharmaceutical agents     
required for such transition4  #a4      
,short title ,this ,act may be cited as 
the ,veteran ,prescription ,continuity  
,act4  #b4 ,improvement to transition of
 care of veterans ,section #gae of the  
,national ,defense ,authorization ,act  
for ,fiscal ,year #bjaf 7,public ,law   
#aad-ib2 #aj ,u4,s4,c4 #ajgd;g note7 is 
amended--  7#a7 by redesignating        
subsections 7c7 through 7f7 as          
subsections 7d7 through 7g71            

respectively2 and  7#b7 by inserting    
after subsection 7b7 the following new  
subsection 7c73  7c7 ,other             
pharmaceutical agents  7#a7 ,critical   
for transition ,the ,secretary of       
,veterans ,affairs shall furnish to an  
individual who is transitioning from    
receiving treatment furnished by the    
,secretary of ,defense to treatment     
furnished by the ,secretary of ,veterans
 ,affairs pursuant to chapter #ag of    
title #ch1 ,united ,states ,code1 any   
pharmaceutical agent not included in the
 joint uniform formulary if a health    
care provider of the ,department of     
,defense determines that such           
pharmaceutical agent is critical for    
such transition4  7#b7 ,duration ,the   
,secretary of ,veterans ,affairs shall  
furnish to an individual a              
pharmaceutical agent under paragraph    
7#a7 during the period--  7,a7 beginning
 on the date on which the individual is 
enrolled in the health care system of   
the ,department of ,veterans ,affairs   

established under section #agje of title
 #ch1 ,united ,states ,code2 and  7,b7  
ending on the date on which a health    
care provider of the ,department        
determines that the individual does not 
require such pharmaceutical agent4  4